These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18240449)

  • 1. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
    Cinti SK; Gandhi T; Riddell J
    AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.
    Silverberg MJ; Abrams DI
    Curr Opin Oncol; 2007 Sep; 19(5):446-51. PubMed ID: 17762569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
    Hessol NA; Pipkin S; Schwarcz S; Cress RD; Bacchetti P; Scheer S
    Am J Epidemiol; 2007 May; 165(10):1143-53. PubMed ID: 17344204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of acquired immunodeficiency syndrome malignancies.
    Goedert JJ
    Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G; Barbarini G
    Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
    Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
    AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy.
    Srisawat N; Avihingsanon A; Praditpornsilpa K; Jiamjarasrangsi W; Eiam-Ong S; Avihingsanon Y
    Transplant Proc; 2008 Oct; 40(8):2677-9. PubMed ID: 18929833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic approaches to AIDS-related malignancies.
    Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
    Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
    Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
    J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non--AIDS-defining malignancies in HIV.
    Mitsuyasu RT
    Top HIV Med; 2008; 16(4):117-21. PubMed ID: 18838745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growing problem of non-AIDS-defining malignancies in HIV.
    Pantanowitz L; Schlecht HP; Dezube BJ
    Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.
    Grulich AE
    Curr Opin HIV AIDS; 2009 May; 4(3):183-7. PubMed ID: 19532048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity.
    Berretta M; Martellotta F; Di Francia R; Spina M; Vaccher E; Balestreri L; Borsatti E; Bearz A; De Paoli P; Tirelli U
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3619-34. PubMed ID: 26502852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy.
    Tyerman Z; Aboulafia DM
    AIDS Rev; 2012; 14(1):3-16. PubMed ID: 22297500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy.
    Grulich AE
    AIDS Read; 2000 Jun; 10(6):341-6. PubMed ID: 10881365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of cancer risk late after AIDS onset in the United States.
    Simard EP; Pfeiffer RM; Engels EA
    Arch Intern Med; 2010 Aug; 170(15):1337-45. PubMed ID: 20696958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.